PDCD1 and neoplasm: Promoting fatty acid catabolism obviously improves the capacity of tumor infiltrating lymphocytes (TILs) to delay tumor growth and synergizes with PD-1 blockade to efficiently boost the efficacy of melanoma immunotherapy (Zhang Y. et al., 2017).